Event Date/Time: Mar 05, 2003
End Date/Time: Mar 07, 2003
After 10 years IBC continues to bring you the leading antibody event in the industry…Antibody Production & Downstream Processing. This must-attend symposium includes a keynote presentation by Dr. Keith Webber, Director, Division of Monoclonal Antibodies, Office of Therapeutic Research and Review, CBER, FDA, and a discussion of regulatory agency experience in prospective manufacturing decision-making by Dr. Anthony R. Mire-Sluis, Principal Advisor to Director-Product Quality, Office of Therapeutic Research and Review, CBER, FDA. This program gives in-depth coverage to the most relevant aspects of antibody manufacturing. Hear from Genentech about their successful expression of full-length immunoglobulins in E.coli as a means of rapid and potentially inexpensive antibody production. Gain from additional perspectives from Lonza Biologics, Genencor, Biogen and others on a variety of expression systems and hear what they are doing to enhance productivity and increase yields. Also, gain from discussion of the latest advances in downstream processing and case studies in process development and scale-up from Abgenix, Protein Design Labs, DSM Biologics, and others.